Stock Updates

AstraZeneca PLC (NYSE: AZN) – Is this large market cap stock undervalued?

AstraZeneca PLC (NYSE: AZN), is firmly in the large market cap category with market cap of 85118.85. To be considered a large market cap stock companies have to be valued at more than $10 billion. The current price for AstraZeneca PLC is 33.82 (with a change from open of -0.50%), this in conjunction with a target price of 36.79. Volume today has so far reached 7552800, with an average volume of about 5981.74. The GAP for this stock, is 1.13%.

The P/E ratio is 38.52, bringing the forward P/E to a value of 12.67. The current EPS for AstraZeneca PLC, is 0.88, with a EPS growth for this year coming to a value of 128.90%. Performance has been interesting with performance year to date coming to 4.21%.

Looking further into the growth statistics for AstraZeneca PLC, EPS is looking like it will grow -10.10% in the next year. Looking even further it is projected to be -1.00%. Quarter over quarter is -100.40% for EPS growth and for sales growth quarter over quarter it is -11.20%. Looking at past EPS growth statistics we see that for the past five years it has been -16.70%. Sales growth for the past five years has in fact been -5.80%.

Looking at the ownership, we see that the insider ownership is at 0.50% and institutional ownership is 12.20%. Shares outstanding is 2516.82, while shares float is at a value of 2503.7. Float short for AstraZeneca PLC is 1.06% and the short ratio is 4.45.

In terms of debt, long term debt/equity is 1.22, while the total debt/equity comes to 1.3. The ability to meet these debts, means that the current ratio is 0.9, and the quick ratio is 0.8. The most recent gross margin is 82.20% and their operating margin is 15.00%. The profit margin is 9.20%.

AstraZeneca PLC has seen returns on assets of 3.70%, and on investment, 11.50%. Return on equity is 13.90%. Price/Earnings to growth ratio is *TBA. Price/Sales ratio is at a value of 3.54, with Price/book ratio coming to 6.32 and Price/cash is 18.32, and finally Price/Free cash Flow is *TBA.

The simple moving averages are 2.31% and 11.91% for 20 day and 200 day simple moving average respectively. For the 52 week high and low the 52 week high is -2.19% and the 52 week low is 27.07%.

AstraZeneca PLC has a dividend yield of 2.66%, with a current price of 33.82. The ability to pay this means the payout ratio is 108.10%. This is in an industry, Drug Manufacturers – Major, with equally high dividends from other companies in this sector, which it is Healthcare. AstraZeneca PLC is based in United Kingdom.

Performance in the Drug Manufacturers – Major industry means that AstraZeneca PLC has seen performance for the past week of 0.21%, with performance for the month coming to 1.56%. Looking at the data for the quarter it is at a value of 14.81%, and for the half year the performance is 13.11%. Volatility for this week is 1.06% and for the month this is 1.30%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment